Alison M. McDonnell

The Kids Research Institute Australia — Australia

Medicine · Health Sciences

18h-index878citations32works4.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(27), Immunotherapy and Immune Responses(20), Immune Cell Function and Interaction(10), CAR-T cell therapy research(9), Occupational and environmental lung diseases(7)

Publications32 total

Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patients
Oxford Open Immunology·2025Open Access
Age-dependent tumor-immune interactions underlie immunotherapy response in pediatric cancer
2025· 2 citedOpen Access
Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapy
Cell Reports Medicine·2024· 6 citedOpen Access
Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade
Journal for ImmunoTherapy of Cancer·2024· 10 citedOpen Access
Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management
Frontiers in Immunology·2022· 17 citedOpen Access
Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations
Frontiers in Immunology·2022· 17 citedOpen Access
Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cells
Burns & Trauma·2022· 5 citedOpen Access
IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies
Frontiers in Immunology·2021· 21 citedOpen Access
Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors
Scientific Reports·2021· 24 citedOpen Access
Malignant Pleural Effusions—A Window Into Local Anti-Tumor T Cell Immunity?
Frontiers in Oncology·2021· 24 citedOpen Access
A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancers
Expert Review of Anticancer Therapy·2021· 2 citedOpen Access
A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancers
Figshare·2021Open Access
Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression
Cells·2021· 23 citedOpen Access
Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy
Frontiers in Immunology·2020· 84 citedOpen Access
Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes
Frontiers in Immunology·2020· 18 citedOpen Access
Cross-Presenting XCR1+ Dendritic Cells as Targets for Cancer Immunotherapy
Cells·2020· 47 citedOpen Access
Immune checkpoint inhibition for the treatment of mesothelioma
Expert Opinion on Biological Therapy·2019· 18 citedOpen Access
Tumour associated lymphocytes in the pleural effusions of patients with mesothelioma express high levels of inhibitory receptors
BMC Research Notes·2018· 15 citedOpen Access
Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters
BMC Cancer·2017· 9 citedOpen Access
PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitors
Lung Cancer·2015· 32 cited
page 1 of 2Next →

Frequent Co-authors

Anna K. Nowak(17), Richard Lake(16), Alistair Cook(10), W. Joost Lesterhuis(9), Bruce Robinson(9), Andrew Currie(7), Jonathan Chee(7), Jason Waithman(7), Michael Millward(6), Nicola Principe(6), Tarek Meniawy(5), Ben Wylie(5), Jenette Creaney(4), Joel Kidman(4), Vanessa S. Fear(4), Katherine M. Audsley(4), Hannah V. Newnes(4), Bree Foley(4), Arman Hasani(3), Caitlin M. Tilsed(3)